Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors

European Journal of Clinical Investigation · Published 2026-07-24 · DOI 10.1111/eci.70243

Free full text

Authors (7)

Leyla Ay, Ingrid Pabinger, Matthias Preusser, Anna Sophie Berghoff, Christoph Hoeller, Cihan Ay, Florian Moik

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ay, L., Pabinger, I., Preusser, M., et al. (2026). Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70243

Related articles